These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3597523)
1. Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon. Martino S; Ratanatharathorn V; Karanes C; Samal BA; Sohn YH; Rudnick SA J Cancer Res Clin Oncol; 1987; 113(4):376-8. PubMed ID: 3597523 [TBL] [Abstract][Full Text] [Related]
2. Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma. Quesada JR; Hawkins M; Horning S; Alexanian R; Borden E; Merigan T; Adams F; Gutterman JU Am J Med; 1984 Sep; 77(3):427-32. PubMed ID: 6548079 [TBL] [Abstract][Full Text] [Related]
3. A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma. Wagstaff J; Loynds P; Crowther D Cancer Chemother Pharmacol; 1986; 18(1):54-8. PubMed ID: 3757160 [TBL] [Abstract][Full Text] [Related]
4. Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma. Leavitt RD; Ratanatharathorn V; Ozer H; Ultmann JE; Portlock C; Myers JW; Kisner D; Norred S; Spiegel RJ; Bonnem EM Semin Oncol; 1987 Jun; 14(2 Suppl 2):18-23. PubMed ID: 3589702 [No Abstract] [Full Text] [Related]
5. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Chisesi T; Capnist G; Vespignani M; Dini E Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691 [No Abstract] [Full Text] [Related]
6. Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma. VanderMolen LA; Steis RG; Duffey PL; Foon KA; Smith JW; Clark JW; Conlon K; Stevenson HC; Urba WJ; Hartmann LC J Natl Cancer Inst; 1990 Feb; 82(3):235-8. PubMed ID: 2296053 [No Abstract] [Full Text] [Related]
8. Reversible cardiac arrhythmia in a breast cancer patient treated with recombinant alpha interferon. Martino S; Samal BA; Sahn YH Breast Cancer Res Treat; 1985; 5(3):327-9. PubMed ID: 4027398 [No Abstract] [Full Text] [Related]
9. Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma. Elsässer-Beile U; Drees N; Neumann HA; Schöpf E J Cancer Res Clin Oncol; 1987; 113(3):273-8. PubMed ID: 3584216 [TBL] [Abstract][Full Text] [Related]
10. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Bunn PA; Ihde DC; Foon KA Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012 [TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. Foon KA; Sherwin SA; Abrams PG; Longo DL; Fer MF; Stevenson HC; Ochs JJ; Bottino GC; Schoenberger CS; Zeffren J N Engl J Med; 1984 Nov; 311(18):1148-52. PubMed ID: 6482933 [TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study. Von Hoff DD; Metch B; Lucas JG; Balcerzak SP; Grunberg SM; Rivkin SE J Interferon Res; 1990 Oct; 10(5):531-4. PubMed ID: 2273299 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of recombinant alpha-interferon and recombinant interleukin-2 metastatic breast cancer. Walters RS; Theriault RL; Holmes FA; Esparza L; Hortobagyi GN J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):303-5. PubMed ID: 7881639 [TBL] [Abstract][Full Text] [Related]
20. Clinical use of interferon alfa-2b (intron-A): the Manchester experience. Scarffe JH; Wagstaff J; Crowther D Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285 [No Abstract] [Full Text] [Related] [Next] [New Search]